Introduction
Immunoglobulin systems containing both high and low molecular weight components that are antigenically closely related or identical have been described in several species. Lower vertebrates such as the smooth dogfish (1) and lemon shark (2) appear to possess a single immunoglobulin system with both high and low molecular weight components showing closest similarity to the human 1gM system. Studies of horse serum have also suggested the existence of a low molecular weight y-globulin antigenically related to the horse 19 S IgM (3) . The occurrence of a similar system in humans was suggested by the findings of Killander (4) and especially those of Rothfield, Frangione, and Franklin (5) . The latter workers showed that certain patients with disseminated lupus possess antinuclear factors of the IgM type having a sedimentation coefficient of approximately 7 S. Also, low molecular weight components possessing IgM determinants have been described in 2 patients with dysproteinemias whose total IgM levels were elevated (6, 7) . The present report demonstrates naturally occurring antibody activity (isohemagglutinins) in low molecular weight IgM fractions and suggests that its occurrence may be more common than previously recognized. The low molecular weight IgM is present in significant amounts in the serum of patients with several disorders including hereditary ataxia telangiectasia, disseminated lupus, and Waldenstr6m's macroglobulinemia. Most importantly, although the low molecular weight IgM appears to be closely related immunologically to the 7 S subunit produced from the macroglobulin by reduction, evidence will be presented suggesting that it is not produced from 19 S IgM, at least by in vitro degradation. The low molecular weight IgM seems to occur particularly in patients with low or absent serum IgA who also have elevated levels of total IgM, although this is not invariably the case. Studies are also presented suggesting a reciprocal relationship between IgA and IgM in the secretions of these patients. In those with low levels of IgA in their secretions, IgA is replaced solely or principally by IgM.
Methods
Parotid saliva was collected with a Curby parotid cup.
Samples of 20 to 100 ml were concentrated 50-fold by negative pressure dialysis. Serum samples were routinely collected approximately 1 hour before use.
Antisera were prepared by immunization of rabbits with purified antigens in Freund's adjuvant or were purchased commercially1 and made specific for each of the immunoglobulins tested by further absorption with purified immunoglobulin preparations. Quantitative determinations of the immunoglobulins were performed using the immunoplate method previously described (8) Analytical and density gradient ultracentrifugation, starch block electrophoresis, and gel chromatography were performed according to methods previously described (9) .
Isohemagglutinin titers are expressed as the reciprocal of the highest dilution giving a 2 + agglutination. The type of immunoglobulin in whole serum and saliva responsible for agglutination was determined by inhibiting the agglutination with antisera specific for IgG, IgA, or IgM as previously described (10) . Incomplete agglutination was tested as follows. Red blood cells of the appropriate blood type were incubated with density gradient or column fractions at room temperature for 30 minutes. The suspension was centrifuged, the supernatant fluid was collected, and the cells were washed three times with saline. The washed, sensitized cells were resuspended in 0.1 ml of saline, and antisera specific for a given immunoglobulin class were added. After gentle mixing for j hour at room temperature the agglutination was read microscopically and graded 1 to 4+. Details of the enzymatic studies of the 19 S IgM immunoglobulin will be the subject of a subsequent report (11) .
Sera were surveyed for low molecular weight IgM by a technique involving double diffusion in polyacrylamide gel. A solution of 4% acrylamide 2 was poured into small petri dishes and allowed to polymerize for 20 minutes in an evacuated dessicator. After polymerization, the gel was crystal clear and firm enough to cut holes in with a no. 2 cork borer. Antisera specific for IgM were placed in the central well and the serum or fractions being tested in the peripheral wells. The plates were incubated for 48 hours at 370 C. The sieving action of the polyacrylamide prevents diffusion of 19 S but not the 7 S IgM. Since the antisera are specific for the ,u chains of IgM, only low molecular weight molecules possessing IgM determinants are detected, even in complex mixtures such as serum.
Results Table I shows the levels of the serum and salivary immunoglobulins in the patients with ataxia 2 Canalco, Bethesda, Md.
telangiectasia. Sinopulmonary infections in these patients varied from mild otitis media or frequent colds to repeated episodes of pneumonia with chronic lung disease and were roughly graded according to frequency and severity from 1 to 4 +. Although serum IgG levels were essentially normal, the IgA levels were markedly decreased or absent in all patients except R.S. Significant elevations of serum IgM were evident in all of the patients. As shown in Table I , low molecular weight IgM was not detected in 3 of the patients with ataxia telangiectasia. These included patients J.V. and G.S., who had the lowest total serum IgM levels, and patient R.S., whose serum IgA level was within normal limits. It is interesting that G.S. and R.S. are brothers, one of whom had low IgA and the other essentially normal levels.
The sera of 52 patients with disseminated lupus were surveyed for the presence of low molecular weight IgM, using the polyacrylamide plate tech- nique. An example of the use of this technique in detecting low molecular weight IgM is illustrated in Figure 1 . The antisera were monospecific and detected only IgM. Evidence that the component being detected was low molecular weight IgM is the fact that, whereas pure preparations of 19 S IgM showed no precipitin line, reduced and alkylated 19 S IgM showed immunological identity with the component detected in the sera studied.
The results of the studies on the lupus patients are summarized in Table II . The incidence of low molecular weight IgM in the sera of these patients was approximately 17%. Of the 7 male patients, 3 or 43%o had 7 S IgM, whereas only 14%o of the female patients possessed this type of immunoglobulin. It is interesting and perhaps significant that all of the lupus patients having low serum IgA levels (less than 0.5 mg per ml, approximately 6%o of the series) possessed the low molecular weight IgM.
Two of 12 patients with Waldenstrbm's macroglobulinemia also demonstrated significant amounts of low molecular weight IgM. This is somewhat lower than the observations of Solomon (12) Figure 2 shows a density gradient determination performed on the fresh serum of a patient, L.C., with hereditary telangiectasia. Although IgM is present in the 19 S region of the gradient, molecules possessing IgM determinants were also found in the 7 S region of the gradient. Similar density gradient patterns demonstrating the 7 S IgM were obtained using the fresh sera of all of the patients whose sera showed the presence of 7 S IgM by the polyacrylamide plate technique. Saline, or direct isohemagglutinins, were present in the 19 S region of the gradient and paralleled the 19 S IgM concentration (Figure 2 ). No direct agglutination was found in the 7 S region of the gradient. However, red blood cells, of the appropriate type, sensitized with fractions from the 7 S region of the gradient were agglutinated using antisera specific for IgM but not with antisera directed against IgG or IgA. Both the direct and indirect agglutination could be inhibited with purified A or B substance, depending on the patient's blood type, and no agglutination of type 0 cells was observed. Addition of purified 19 S IgM inhibited both the direct and indirect agglutination, whereas addition of IgG or IgA had no effect on either type of agglutination. alkylation destroyed the saline isohemagglutinin activity, but had no effect on the incomplete isohemagglutination. The serum of patient L.C. was fractionated by starch block electrophoresis. Fractions containing IgM were pooled, concentrated, and applied to a Bio-Gel P300 column. The elution pattern (Figure 3) demonstrates two distinct populations of IgM. The fall through or first peak contains high molecular weight IgM having an uncorrected sedimentation coefficient of 18.3 S. The second fraction of IgM was eluted early in the second peak with the IgG. The initial fractions of the second peak having a high ratio of IgM to IgG (approximately 1: 1) showed a single symmetrical boundary in the ultracentrifuge, having an uncorrected sedimentation coefficient of 6.4 S. Density gradient analysis of this fraction (Figure 4) showed that the distribution of the low molecular weight IgM is similar to that of 7 S IgG.
Using the fraction from peak two of the Bio-Gel column containing essentially only IgG and 7 S IgM (as determined immunologically), we were able to determine the approximate concentration The patients' sera were incubated at 370 C for 96 hours to determine whether dissociation of 19 S IgM occurred in uitro. Incubation had no effect on the quantitative distribution of high versus low molecular weight IgM on density gradient analysis. Freezing and thawing or storage at 40C for several weeks had no effect on the quantity of 7 S IgM, although this treatment did significantly de- crease the indirect isohemagglutinin titer. The amount of 7 S IgM was constant in sera collected at 3-week intervals although one patient's low molecular weight IgM was significantly reduced after an undiagnosed respiratory infection.
The presence of low molecular weight IgM is not directly related to the absolute concentrations of IgM. This is illustrated by the fact that 10 of 12 patients with Waldenstr6m's macroglobulinemia, despite very high concentrations of IgM, had no detectable 7 S IgM in their serum. No low molecular weight IgM was found in the serum of several patients with Laennec's cirrhosis and infectious mononucleosis who had total IgM levels comparable to the patients possessing low molecular weight IgM. The low molecular weight IgM could not be detected in any of 15 normal sera using the polyacrylamide gel technique. Analysis of the sera of 3 normal subjects with a singular deficiency of serum IgA also failed to demonstrate the presence of low molecular weight IgM. Low molecular weight IgM, was not found in the parents of patients L.C. and M.F.
As shown in Figure 5 , gel diffusion analysis using antisera against normal 19 S IgM yielded a pattern of identity between the patient's 7 S IgM, 19 S IgM isolated from the same sera, reduced and alkylated 19 S IgM, and normal human serum. Note especially that the 7 S IgM is not antigenically deficient to the 19 S IgM. However, the 6.6 S subunits produced by chymotrypsin C digestion of 19 S IgM are deficient to both the 19 S and the 7 S IgM. Identical results were obtained using two other anti-IgM antisera.
IgA could not be detected in the saliva of those patients whose serum lacked IgA (Table I ). The reason for the difference between these results and those reporting normal salivary IgA levels with absent serum IgA in patients with ataxia telangiectasia (13) is not known. Our results are in agreement with those of South, Cooper, and Wollheim (14) .
In patients lacking salivary IgA, IgM was the sole or major immunoglobulin present in the saliva, and the concentration of IgM equaled or exceeded the total y-globulin concentration of normal saliva. As the concentration of IgA in the saliva increased, the concentration of IgM tended to decrease. This reciprocal relation between IgA and 1gM has been noted in the saliva of several patients with other disorders not included in this report. IgG was not detected in the saliva of any of the patients, despite normal serum IgG concentrations.
No low molecular weight IgM was found in the saliva. This may indicate difficulties in quantitation rather than a lack of 7 S IgM. Small amounts of IgM are present in saliva relative to the amounts in serum, and if only 10%o of the salivary IgM were low molecular weight, as in serum, it would not have been detected with the techniques employed.
It is interesting to note that the isohemagglutinin titers in the serum and saliva of the patients with ataxia telangiectasia were essentially normal and bear no apparent relation to the frequency of infection (Table I) . Isohemagglutination in both the serum and saliva of the patients with ataxia telangiectasia could be inhibited with antisera against IgM, but not with antisera against IgG or IgA.
Discussion
Our findings that 17% of patients with disseminated lupus have 7 S IgM are comparable to those of Rothfield and her colleagues (5), who reported an incidence of 15% for low molecular weight IgM antinuclear factor in patients with systemic lupus erythematosus. Also of interest is the high incidence of males with 7 S IgM, findings again similar to those of Rothfield. The 7 S IgM seems to occur with particularly high frequency in lupus patients having low serum IgA, although more patients must be studied before a definite relationship is established.
The 7 S IgM found in the serum of these patients seems to occur naturally and is not formed from the high molecular weight IgM, at least as tested under in vitro conditions. Although the incubation experiments suggest that reductive cleavage does not occur in vitro in serum, it could occur in vivo perhaps intracellularly, by proteolysis, or by some type of disulfide interchange reaction. Since storage of preparations containing reasonably high concentrations of 7 S IgM does not result in reaggregation, it would be expected that if free sulfhydryl 'groups are formed intracellularly, they. are either'blocked or buried, and thus are unreactive.
The low molecular weight IgM is similar to the 7 S subunits produced by reduction of the 19 S protein in two respects: 1) Unlike the. 6.6 S subunits produced by enzymatic degradation, it shows immunological identity with 19 S IgM. It is not known, however, whether the naturally occurring 7 S IgM contains antigenic determinants that are either not present or are buried in the native 19 S IgM and its reductive subunit. Work is now in progress attempting to prepare antisera specific for the 7 S IgM. 2) The 7 S IgM may possess univalent antibody activity as suggested by the finding of only indirect isohemagglutination, although further studies are necessary to establish this point with certainty. It is of interest that univalent-like antibody activity has been reported with the 7 S reductive subunits by several workers (15) (16) (17) .
The 7 S IgM is similar in its sedimentation properties to IgG. The small differences noted between the 7 S IgM and IgG in their distribution on the Bio-Gel column may indicate differences in either molecular size or shape. These findings are consistent with the observations of Miller and Metzger (18) demonstrating significant differences in the elution patterns of the H chains of IgM and IgG on Sephadex G-200. This was found to be a result of the higher molecular weights of the H polypeptide chain of IgM. However, whether the differences noted in our studies are indeed significant awaits verification by molecular weight determinations on purified preparations of 7 S IgM.
The evolution of the immune response is thought to parallel rather closely the development of the lymphoid system, particularly the thymus (19) . As previously mentioned, both the smooth dogfish and lemon shark, whose thymic development is intermediate between the lowest vertebrate and man (20) , have a single immunoglobulin system most closely related, by starch gel electrophoresis, to the human IgM system. In this species, both 7 S and 17 S immunoglobulins exist that are antigenically identical, a situation quite similar to the IgM system described in our patients. It is interesting, therefore, that thymic hypoplasia, lymphopenia, and dysplasia of the lymphoreticular system have been reported in ataxia telangiectasia (21) (22) (23) and, although the evidence is less convincing, in disseminated lupus (24, 25 
